A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
CompletedOBSERVATIONAL
Enrollment
26
Participants
Timeline
Start Date
April 24, 2000
Primary Completion Date
December 31, 2012
Study Completion Date
March 10, 2020
Conditions
Ovarian Neoplasm
Trial Locations (1)
20892
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001938 - A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) | Biotech Hunter | Biotech Hunter